Novo CEO pressed by Senate to chop costs of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would look at new talks with insurers with regard to the listing costs of Wegovy and copyright whenever they pledge to help keep the medicines on their https://kethek.com/